A new discovery points towards a possible treatment for non-healing, diabetic wound care

Upon uncovering that inadequate blood flow can be a more imminent, life-threatening problem than aortic rupture for some patients, doctors emerge with a new procedural method.

Genetic Origin of Severe Developmental Eye Condition Identified

How unexpected awakenings in dementia patients might shed new light on the disease, according to University of Michigan researcher and colleagues

A study in rats has revealed the presence of naturally occurring dimethyltryptamine (DMT), an increasingly popular hallucinogen.

Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.

U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.

Forty percent of people who develop venous thromboembolism don’t know what caused it. New research in mice further explores inflammation’s role.

Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.

A 600-patient randomized clinical trial supports pembrolizumab and chemotherapy as a first-line treatment

The largest study of its kind finds societal factors and access to quality care, rather than genetics, underlies higher prostate cancer mortality rates for black men.

New research shows that a combination of two immune-system factors could open up new avenues for treating diabetes and obesity.

A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.

Researchers identify genetic variants that lead to a severe developmental syndrome. The findings could mean better screening and diagnosis for patients with inherited syndromes.